Cardiovascular Laboratory Trend Tables

Purpose

The purpose of this section is to document cardiovascular laboratory changes over time by organizing key markers into longitudinal tables.

These tables allow trends to be easily reviewed by:

  • Patient
  • Primary care physician
  • Cardiologist
  • Future healthcare providers

The focus is on:

  • Lipid patterns.
  • Advanced cardiovascular markers.
  • Inflammatory risk markers.
  • Metabolic factors affecting cardiovascular health.

Table 1 — Standard Lipid Trends

DateTotal CholesterolLDL-CHDL-CTriglyceridesNon-HDL
June 20242201367550145
November 20242431419452149
December 20252561518960167
June 20262841838285

Trend Summary

Positive Findings

  • HDL has remained consistently high.
  • Triglycerides have remained low.
  • Lipid pattern reflects strong metabolic health.

Area for Monitoring

  • LDL cholesterol has increased and requires continued physician evaluation.

Table 2 — Advanced Cardiovascular Markers

DateApoBLDL Particle NumberLipoprotein(a)
June 2025
November 2025
June 20261392483Low

Trend Summary

Advanced testing identifies:

  • Increased atherogenic particle burden.
  • Favorable Lipoprotein(a) status.

These findings should be interpreted with:

  • Inflammation.
  • Metabolic health.
  • Cardiac history.

Table 3 — Cardiovascular Inflammation & Metabolic Support Markers

DateCRPESRGlucoseA1cInsulin
October 20213271
June 20242
November 20241
June 20266665.52.1

Trend Summary

The cardiovascular environment has improved significantly:

  • Inflammation resolved.
  • Glucose regulation excellent.
  • Insulin sensitivity excellent.

Overall Cardiovascular Trend Summary

The laboratory trends demonstrate:

Strengths

✓ Very high HDL
✓ Low triglycerides
✓ Excellent glucose regulation
✓ Very low inflammatory markers
✓ Low Lipoprotein(a)

Areas Requiring Monitoring

✓ LDL cholesterol
✓ ApoB
✓ LDL particle number
✓ Blood pressure history
✓ Cardiac history


Current Cardiovascular Assessment

The overall cardiovascular laboratory pattern is:

A metabolically favorable profile with excellent inflammatory control and strong metabolic markers, combined with elevated LDL-related particle measures requiring individualized cardiology assessment.


Related Sections

  • Section 3.1 — Hypertension
  • Section 3.2 — Hyperlipidemia
  • Section 3.3 — History of Atrial Fibrillation
  • Section 3.4 — Ascending Aortic Aneurysm
  • Section 7.2.4 — Cardiovascular Trends
  • Section 8 — Physician Consultation Summaries

Navigation

Previous Section: Section 7.3.1 — Inflammation Trend Tables
Current Section: Section 7.3.2 — Blood Health Trend Tables
Next Section: Section 7.3.3 — Cardiovascular Trend Tables
Return to Section 7 — Laboratory Archive